MLH1 and neoplasm: The study scrutinized 19 nondysplastic BE specimens and 145 EAC samples, exposing pronounced methylation of the MLH1 promoter in all MSI‐H cases, with only one tumor displaying MLH1 hypermethylation in MSS.